Summary
A gas chromatographic method has been employed to determine chlorthalidone in plasma and whole blood after therapeutic doses. Radioactively labelled chlorthalidone was used for in vitro studies of the uptake of chlorthalidone from plasma by red blood cells. Chlorthalidone was markedly concentrated in red cells and as a compartment they would account for at least 30% of total drug in the body after multiple doses. The ratio between the plasma and red cell concentration of chlorthalidone varied between individuals. After a single oral dose of 50 mg in 6 healthy volunteers chlorthalidone was eliminated with a half-life of 51 to 89 hours. The apparent volume of distribution varied between 3 and 13 1/kg and the clearance between 53 and 145 ml/min. The mean steady-state plasma concentrations during treatment with a standard dose of 50 mg daily (n=10) varied 5-fold between individuals. During the steady state approximately 50% of the daily dose was excreted unchanged in the urine during 24 hrs. The plasma levels observed in patients were higher than those predicted from the single oral dose studies in healthy volunteers.
Similar content being viewed by others
References
Alexanderson, B.: On interindividual variability in plasm levels of nortriptyline and desmethylimipramine in man: a pharmacokinetic and genetic study. Linköping, University Medical Dissertations No. 6, 1972
Beerman, B., Hellström, K., Lindström, B., Rosén, A.: Binding-site interaction of chlorthalidone and acetazolamide, two drugs transported by red blood cells. Clin. Pharmacol. Ther.17, 424–432 (1975)
Dixon, W.J., Massey, F.J., Jr.: Introduction to statistical analysis. New York: McGraw-Hill Book Co. 1969
Ehrnebo, M., Agurell, S., Jalling, B., Boreus, L.-O.: Age differences in drug binding by plasma proteins: studies on human fetuses, neonates and adults. Europ. J. clin. Pharmacol.3, 189–193 (1971)
Ervik, M., Gustavii, K.: Application of the extractive alkylation technique to the gas chromatographic determination of chlorthalidone in plasma in nanogram quantities. Anal. Chem.46, 39–42 (1974)
Maren, T.H.: Carbonic anhydrases chemistry, physiology and inhibition. Physiol. Rev.47, 595–781 (1967)
Sjöqvist, F., von Bahr, C.: Interindividual differences in drug oxidation: clinical importance. Drug. Metab. Disp.1, 469–482 (1973)
Thomson, A.E.: Chlorthalidone in the long term treatment of patients with hypertension. Int. J. clin. Pharmacol.3, 21–25 (1970)
Tweedale, M.G., Ogilvie, R.I.: Absorption and excretion of chlorthalidone (Hygroton) in man. Clin. Res.20, 913 (1972)
Tweedale, M.G., Ogilvie, R.I.: Improved method for estimating chlorthalidone in body fluids. J. pharm. Sci.20, 1065–1068 (1974)
Author information
Authors and Affiliations
Additional information
A preliminary report of this paper was presented at the Ann. Meet. Sw. Med. Soc. Nov. 1973
Supported by a Geigy scholarship
Rights and permissions
About this article
Cite this article
Collste, P., Garle, M., Rawlins, M.D. et al. Interindividual differences in chlorthalidone concentration in plasma and red cells of man after single and multiple doses. Eur J Clin Pharmacol 9, 319–325 (1976). https://doi.org/10.1007/BF00561667
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00561667